Karina Calzadilla | Head, IR |
Chad Robins | CEO and Co-founder |
Tycho Peterson | CFO |
Nitin Sood | Chief Commercial Officer, MRD |
Harlan Robins | Chief Scientific Officer and Co-founder |
Sharon Benzeno | Chief Commercial Officer, Immune Medicine |
Rachel Vatnsdal | JPMorgan Chase |
Dan Brennan | TD Cowen |
David Westenberg | Piper Sandler |
Mark Massaro | BTIG |
Elizabeth Webster | Goldman Sachs |
Yuko Oku | Morgan Stanley |
Dan Leonard | Credit Suisse |
Derik de Bruin | Bank of America |
Sharon Benzeno | Chief Commercial Officer, Immune Medicine |
Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be question-and-answer session. [Operator Instructions] Pleased be advised that today’s conference is being recorded.